Literature DB >> 25705303

Intellectual disability and epilepsy in down syndrome.

Diana Barca1, Oana Tarta-Arsene1, Alice Dica2, Catrinel Iliescu1, Magdalena Budisteanu3, Cristina Motoescu4, Niculina Butoianu1, Dana Craiu1.   

Abstract

UNLABELLED: Down Syndrome (DS) is the most common genetic cause of mental retardation, with a reported frequency of epilepsy between 1.4-17% (1). There is a paucity of data in the literature regarding epilepsy in Down syndrome and its relation to intellectual disability.
OBJECTIVES: The purpose of this article is to analyze the association of epilepsy in children with DS - frequency and type of seizures, treatment, outcome and to compare cognitive impairment of children with DS and epilepsy and DS without epilepsy from our cohort.
METHODS: A four years systematic retrospective analysis of the database of the Pediatric Neurology Clinic (January 2010 - December 2013) identified a cohort of 39 pediatric cases with DS and neurological symptoms, 9 of them (23%) associating epileptic seizures. Following data were analysed: clinical and neurological examination, type/s of seizures, electroencephalography (EEG), cerebral magnetic resonance imaging (MRI), psychological examination, psychiatric evaluation in selected cases, electrocardiography (ECG), cardiac ultrasonography, ophthalmologic examination.
RESULTS: 23% (9 patients) of the children with DS of our cohort presented epilepsy. Five patients had epileptic spasms (56%), one of these further developed astatic seizures. Focal seizures were observed in three patients (33%) and absence with eyelid myoclonias in one patient (11%). Two of the nine patients with DS and epilepsy had generalized seizures, both with very good response to levetiracetam (LEV). EEG was abnormal at seizure onset, and was improved after treatment. Of the nine children with DS and epilepsy, two (22%) presented mild mental retardation and seven (78%) had moderate to severe cognitive delay. Of the 30 children with DS and without epilepsy, 21 (70%) had mild mental retardation and 9 (30%) had moderate to severe cognitive impairment.
CONCLUSIONS: The most frequent epileptic syndrome associated with DS is West syndrome, with good response to specific antiepileptics. All children with DS from our cohort have intelectual disability, more severe in those with epilepsy. Slight improvement of intelectual and language capabilities were seen after seizures control.

Entities:  

Year:  2014        PMID: 25705303      PMCID: PMC4316878     

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  14 in total

1.  Electroclinical features and long-term outcome of cryptogenic epilepsy in children with Down syndrome.

Authors:  Alberto Verrotti; Raffaella Cusmai; Francesco Nicita; Antonella Pizzolorusso; Maurizio Elia; Nelia Zamponi; Elisabetta Cesaroni; Tiziana Granata; Ilaria De Giorgi; Lucio Giordano; Salvatore Grosso; Piero Pavone; Emilio Franzoni; Giangennaro Coppola; Caterina Cerminara; Paolo Curatolo; Salvatore Savasta; Pasquale Striano; Pasquale Parisi; Antonino Romeo; Alberto Spalice
Journal:  J Pediatr       Date:  2013-08-27       Impact factor: 4.406

Review 2.  [Epilepsy in chromosome aberrations].

Authors:  N Bahi-Buisson; D Ville; M Eisermann; P Plouin; A Kaminska; C Chiron
Journal:  Arch Pediatr       Date:  2005-04       Impact factor: 1.180

3.  Epilepsy in adult patients with Down syndrome: a clinical-video EEG study.

Authors:  Aglaia Vignoli; Elena Zambrelli; Valentina Chiesa; Miriam Savini; Francesca La Briola; Elena Gardella; Maria Paola Canevini
Journal:  Epileptic Disord       Date:  2011-06       Impact factor: 1.819

4.  Seizure frequency and characteristics in children with Down syndrome.

Authors:  H Goldberg-Stern; R H Strawsburg; B Patterson; F Hickey; M Bare; N Gadoth; T J Degrauw
Journal:  Brain Dev       Date:  2001-10       Impact factor: 1.961

5.  Health supervision for children with Down syndrome.

Authors:  Marilyn J Bull
Journal:  Pediatrics       Date:  2011-07-25       Impact factor: 7.124

6.  Infantile spasms in Down syndrome: good response to a short course of vigabatrin.

Authors:  R Nabbout; I Melki; B Gerbaka; O Dulac; C Akatcherian
Journal:  Epilepsia       Date:  2001-12       Impact factor: 5.864

Review 7.  Epilepsy in children with Down syndrome.

Authors:  Ravindra Arya; Madhulika Kabra; Sheffali Gulati
Journal:  Epileptic Disord       Date:  2011-03       Impact factor: 1.819

8.  [Neurological complications in Down syndrome].

Authors:  A Chaanine; C Hugonenq; G Lena; J Mancini
Journal:  Arch Pediatr       Date:  2008-03-10       Impact factor: 1.180

9.  Infantile spasms and Down syndrome: a new animal model.

Authors:  Miguel A Cortez; Liqing Shen; Ying Wu; Ilyas S Aleem; Catherine H Trepanier; Hamid R Sadeghnia; Asim Ashraf; Ashlin Kanawaty; Chen-Chu Liu; Lee Stewart; O Carter Snead
Journal:  Pediatr Res       Date:  2009-05       Impact factor: 3.756

10.  Sudden unexpected death in people with down syndrome and epilepsy: another piece in this complicated puzzle.

Authors:  Carla A Scorza; Fulvio A Scorza; Ricardo M Arida; Esper A Cavalheiro
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

View more
  3 in total

Review 1.  New approaches to studying early brain development in Down syndrome.

Authors:  Ana A Baburamani; Prachi A Patkee; Tomoki Arichi; Mary A Rutherford
Journal:  Dev Med Child Neurol       Date:  2019-05-17       Impact factor: 5.449

Review 2.  Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome.

Authors:  Laszlo Pecze; Elisa B Randi; Csaba Szabo
Journal:  Mol Med       Date:  2020-11-09       Impact factor: 6.354

3.  Health comorbidities and cognitive abilities across the lifespan in Down syndrome.

Authors:  Carla M Startin; Hana D'Souza; George Ball; Sarah Hamburg; Rosalyn Hithersay; Kate M O Hughes; Esha Massand; Annette Karmiloff-Smith; Michael S C Thomas; Andre Strydom
Journal:  J Neurodev Disord       Date:  2020-01-23       Impact factor: 4.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.